FDA drug shortage status

Is Benztropine Mesylate Injection in shortage?

Benztropine Mesylate Injection is listed by FDA as being discontinued by at least one maker (updated Jan 27, 2026).

Being discontinuedFDA status

1packages listed

0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
Fresenius Kabi USA, LLCBeing discontinuedUpdated Jan 27, 2026Discontinued Jan 27, 2026
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300

FDA recalls of Benztropine Mesylate

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Benztropine Mesylate Injection:

Fresenius Kabi USA, LLC recalls Benztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/1 mL), 2 mL Single Dose Vial, Rx only, labeled as a) Manufactured
Jul 1, 2013Class II

Benztropine Mesylate Injection shortage questions

Is Benztropine Mesylate Injection in shortage?

Benztropine Mesylate Injection is listed by FDA as being discontinued by at least one maker (updated Jan 27, 2026).

What should I do if I can’t get Benztropine Mesylate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.